COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 138 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 9 | -47.1% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 17 | -95.7% | 0.00% | -100.0% |
| Q3 2020 | $8,000 | -83.0% | 396 | -85.5% | 0.00% | -66.7% |
| Q2 2020 | $47,000 | -13.0% | 2,727 | -18.9% | 0.00% | -25.0% |
| Q1 2020 | $54,000 | -36.5% | 3,362 | -18.1% | 0.00% | -20.0% |
| Q4 2019 | $85,000 | -12.4% | 4,106 | -51.7% | 0.01% | -16.7% |
| Q3 2019 | $97,000 | +1112.5% | 8,495 | +1299.5% | 0.01% | +500.0% |
| Q2 2019 | $8,000 | -76.5% | 607 | -73.8% | 0.00% | -66.7% |
| Q1 2019 | $34,000 | -45.2% | 2,318 | -36.9% | 0.00% | -50.0% |
| Q4 2018 | $62,000 | +785.7% | 3,672 | +644.8% | 0.01% | +500.0% |
| Q3 2018 | $7,000 | -100.0% | 493 | -85.4% | 0.00% | -85.7% |
| Q2 2018 | $80,637,000 | +8063600.0% | 3,381 | +6401.9% | 0.01% | – |
| Q1 2018 | $1,000 | 0.0% | 52 | +4.0% | 0.00% | – |
| Q4 2017 | $1,000 | -90.0% | 50 | -94.5% | 0.00% | -100.0% |
| Q1 2017 | $10,000 | +42.9% | 902 | +101.3% | 0.00% | 0.0% |
| Q4 2016 | $7,000 | – | 448 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |